[ad_1]
Mumbai: With an purpose to broaden entry to Pfizer’s revolutionary medication to sufferers, the corporate launched ‘Pfizer PAP India’—a cell software designed to ease and fast-track enrollment to Pfizer’s Affected person Entry Programmes (PAP).
The cell software, out there on each iOS and Android platforms, is designed to help sufferers who want to be part of the corporate’s Affected person Entry Programme. The cell software presents eligible sufferers remedy help, primarily based on a sound prescription by the treating doctor and the submission of different required paperwork by the affected person.
“The Pfizer PAP India app presents them a one-stop answer to satisfy this objective on the contact of a button, ” mentioned Satyen Amin, Director- Industrial Channel and Market Entry, Pfizer India.
Sufferers can enrol within the programme by importing the required paperwork. The affirmation of enrolment into the programme nevertheless is topic to the affected person’s medical eligibility, and verification of required paperwork.
Talking concerning the launch, Dr Rahul Bhargava, Director & HOD – Division of Hematology & BMT, Fortis hospital Gurgaon mentioned, “We imagine that entry to medicines and drugs adherence determines remedy effectiveness. These are a few of the most helpful interventions for enhancing well being outcomes. Nevertheless, that is potential solely by way of common affected person monitoring and entry to revolutionary medicines. By PAP app, sufferers can now seamlessly navigate their well being journey on a single platform the place they’re enrolled. We’re sure that this endeavour will profit the healthcare ecosystem in addition to the sufferers.”
PAP is executed by Tata 1 MG (MediAngels by TATA 1MG) on behalf of Pfizer India. “Now sufferers will be capable to avail all of the relevant providers straight and seamlessly by utilizing the cell software,” mentioned Prashant Tandon, Cofounder & CEO, Tata 1 MG.
[ad_2]
Source link
